Latest Global Expansion Strategy News

ALS Limited reported a robust half-year performance with underlying revenue up 13.3% and net profit after tax rising 17.2%, driven by strong growth in both Commodities and Life Sciences divisions. The company also declared a higher interim dividend and advanced its global expansion strategy.

Tungsten Mining has secured a listing on the US OTCQB exchange and launched a Denver office, marking a strategic push into North America’s critical minerals market.

Neuren Pharmaceuticals reported a milestone quarter with DAYBUE net sales reaching US$101.1 million, driving a 24% jump in royalty income. The expanding patient base and community physician uptake signal strong growth ahead.

Pureprofile Limited has reported record Q1 FY26 revenue and EBITDA growth, with international markets overtaking its traditional ANZ base for the first time. The company’s AI-driven platform innovations and global expansion strategy are driving this milestone.

Nova Eye Medical has gained regulatory approval for its iTrack Advance glaucoma device in China, setting the stage for significant market expansion and sales growth from late fiscal 2026.

EQ Resources Limited has appointed industry veteran Craig Bradshaw as Managing Director, marking a strategic leadership transition to drive growth in global tungsten mining.

Nanoveu Limited’s transformative half-year report highlights its EMASS acquisition, executive hires, and technology advances amid a $3 million loss and new US OTCQB listing.

Advanced Health Intelligence Ltd has secured up to AUD 5.5 million from Oakley Capital Partners to support its ASX reinstatement and global expansion, while targeting an additional USD 6 million and unlocking $3 million in R&D grants.

RooLife Group has agreed to sell its Australian digital marketing subsidiary CHOOSE Digital for $356,500, marking a strategic pivot towards high-margin international product sales.

Titomic’s Netherlands division has secured €800,000 in funding from the Dutch 3D Print Kompas program to advance its Cold Spray Additive Manufacturing technology, aiming to expand R&D and industrial applications across Europe.

Proteomics International has achieved a major milestone with the first worldwide patent granted in Japan for its PromarkerEndo blood test, designed to diagnose endometriosis early and accurately.

Ionic Rare Earths is advancing plans for multiple magnet recycling plants in the US, leveraging patented technology to produce high-purity rare earth oxides amid growing demand for sovereign supply chains.